GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

ECO Animal Health Group EAH.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

81.00p

-2.99%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2026

Revenue

£87.5m

FY2017FY2026

Net income

£2.2m

FY2017FY2026

Free cash flow

£7.5m

FY2017FY2026

Shareholders' equity

£87.1m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue£87.5m£79.6m£89.4m£85.3m£82.2m£105.6m£72.1m£67.3m£67.2m£61.4m
Gross profit£42.5m£35.9m£37.7m£36.8m£33.7m£51.5m£32.4m£31.8m£32.2m£30.3m
Research and development£5.3m£4.0m£4.2m£5.9m£8.8m£8.1m£8.8m£5.9m£81,000£36,000
Operating income£5.4m£4.3m£3.5m£5.1m£4.5m£16.9m£6.5m£10.1m£14.1m£12.9m
Net income£2.2m£1.7m£1.0m£1.0m−£686,000£7.3m£3.9m£7.3m£9.3m£10.6m
Diluted earnings per share0.030.020.020.01-0.010.110.060.110.140.16

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets£118.6m£120.6m£123.3m£121.3m£113.6m£116.9m£100.0m£106.1m£117.2m£113.8m
Cash and short-term investments£25.4m£25.0m£22.4m£21.7m£14.3m£19.5m£11.9m£16.9m£21.3m£20.6m
Total liabilities£23.1m£25.8m£29.9m£25.8m£19.3m£21.6m£19.5m£16.5m£12.3m£15.6m
Debt£4.9m£3.8m£4.0m£4.5m£1.9m£1.5m£3.8m£1.8m——
Shareholders' equity£87.1m£85.5m£83.7m£83.3m£82.1m£81.9m£74.7m£84.5m£99.7m£93.8m
Shares outstanding69m68m68m68m68m68m70m68m68m66m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations£7.7m£10.4m£9.4m£15.9m−£548,000£12.0m£4.4m£6.3m£14.1m£11.8m
Capital spending−£192,000−£5.0m−£4.6m−£6.0m−£2.9m−£1.1m−£2.9m−£566,000−£324,000−£265,000
Free cash flow£7.5m£5.4m£4.8m£9.9m−£3.4m£10.9m£1.5m£5.7m£13.7m£11.5m
Dividends paid−£2.5m−£1.1m−£2.8m−£1.8m−£2.9m−£562,000−£8.4m−£10.1m−£6.0m−£4.3m

Latest quarters

By quarter end

Mar 2026Sept 2025Mar 2025Sept 2024Mar 2024Sept 2023Jun 2023Mar 2023
Revenue£48.1m£39.4m£46.4m£33.2m£51.4m£38.0m£19.0m£50.5m
Gross profit£22.9m£19.6m£22.6m£13.4m£22.2m£15.5m£7.8m£22.6m
Operating income£4.5m£1.0m£5.6m−£1.3m£4.1m−£612,000−£375,000£3.8m
Net income£2.6m−£363,000£3.4m−£1.7m£2.4m−£1.3m−£603,000−£317,000
Diluted earnings per share0.04-0.010.05-0.030.03-0.02-0.01-0.00
Cash from operations£8.0m−£1.0m£10.0m—£4.0m£4.0m—£14.0m
Capital spending———————−£2.0m
Free cash flow———————£12.0m
Total assets£118.6m£114.0m£120.6m£111.7m£123.3m£115.3m£115.3m£121.3m
Cash and short-term investments£25.4m£18.6m£25.0m£18.3m£22.4m£20.6m£20.6m£21.7m
Debt£760,000£754,000£621,000£574,000£646,000£934,000£3.2m£884,000
Shareholders' equity£87.1m£84.8m£85.5m£82.2m£83.7m£81.5m£90.6m£83.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.9%-3.7%6.4%
Operating income2.2%-20.4%-3.2%
Net income29.5%-21.5%-9.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin46.9%44.7%45.0%45.7%
Operating margin5.8%5.4%7.5%10.7%
Net margin2.3%1.7%2.4%5.9%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings30.042.045.972.9-100.214.844.719.429.837.5
Price to sales0.80.90.50.90.81.02.42.14.16.4

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 23 Sept 2021.

FY2022FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Paid in the year0.010.070.1350.0780.0630.0540.0660.044
  • 6-for-2 split · 18 Oct 2002

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.